Sea Limited Receives Rating Boost and Raised Price Target from Macquarie

Citizens JMP lowered AMN Healthcare's price target to $22 from $33 and maintained an Outperform rating. The analyst is encouraged by stable Q3 order and extension trends, despite near-term staffing trends remaining choppy. The longer-term risk/reward profile of shares remains attractive, the firm says.

AMN Healthcare (NYSE: AMN) has seen a significant shift in its price target following the company's second-quarter 2025 earnings report. BMO Capital recently lowered its price target on AMN Healthcare from $27 to $22, while maintaining an Outperform rating [1]. This move comes on the heels of AMN Healthcare's earnings report, which exceeded consensus estimates despite a year-over-year decline in earnings per share (EPS) and revenues.

The company reported an adjusted EPS of $0.30, surpassing the forecasted $0.18, and revenue of $658.18 million, which was slightly above the projected $652.63 million [2]. Despite these positive earnings figures, AMN Healthcare's stock has experienced a decline, reflecting broader market uncertainties and concerns over a net loss. The company's stock has declined over 70% in the past year, though InvestingPro analysis suggests the company is currently undervalued based on its Fair Value assessment [1].

BMO Capital noted that recent government policies and macroeconomic volatility have negatively impacted healthcare staffing volumes, with Academic Medical Centers that rely on federal funding experiencing the most significant declines [1]. The research firm reported some stabilization in July, but AMN's third-quarter 2025 revenue guidance came in below consensus expectations due to the volume decreases [1].

Citizens JMP, another analyst firm, also lowered AMN Healthcare's price target to $22 from $33 while maintaining an Outperform rating. The analyst is encouraged by stable Q3 order and extension trends, despite near-term staffing trends remaining choppy. The longer-term risk/reward profile of shares remains attractive, the firm says [3].

AMN Healthcare's stock price currently stands at $16.50, reflecting a decrease of 4.29% with a change of $0.74. The stock has fluctuated between a low of $16.45 and a high of $17.59 during the day. Over the past year, AMN has reached a high of $59.19 and a low of $14.87. The company's market capitalization is approximately $631.7 million, with a trading volume of 574,738 shares on the NYSE [3].

Investors continue to monitor these developments closely as they assess the company’s financial health. Despite the recent earnings beat and positive revenue figures, the company's stock experienced a decline, reflecting broader market uncertainties and concerns over a net loss. Analyst firms have not issued any recent upgrades or downgrades for AMN Healthcare.

References:
[1] https://www.investing.com/news/analyst-ratings/amn-healthcare-stock-price-target-lowered-to-22-from-27-at-bmo-capital-93CH-4183168
[2] https://finance.yahoo.com/news/amn-healthcare-services-second-quarter-133140781.html
[3] https://site.financialmodelingprep.com/market-news/amn-healthcare-nyse-amn-financial-analysis-price-target